This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through July 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
earnings-performance: Archive
JPMorgan Chase & Co. (JPM) Up 5.3% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
JPMorgan Chase & Co. (JPM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
JPMNegative Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Why Is Goldman (GS) Down 10% Since Last Earnings Report?
by Zacks Equity Research
Goldman (GS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
GSNegative Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Why Is Helen of Troy (HELE) Up 5.1% Since Last Earnings Report?
by Zacks Equity Research
Helen of Troy (HELE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
HELENegative Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Boston Scientific's 2026 Guidance Cut Puts Its Recovery to the Test
by Urmimala Biswas
Boston Scientific's 2026 guidance cut tests its recovery as WATCHMAN weakness, EP share losses and delayed margin gains push a broader rebound toward 2028.
BSXPositive Net Change ABTPositive Net Change ZBHPositive Net Change
earnings earnings-beat earnings-consensus earnings-esp earnings-estimates earnings-estimates-revisions earnings-expectations earnings-growth earnings-outlook earnings-performance earnings-report earnings-surprise earnings-trend medical medical-devices
Should Investors Buy Boston Scientific Stock Despite Near-Term Risks?
by Urmimala Biswas
Boston Scientific's cheaper valuation offers upside, but weaker guidance, share losses, higher debt and delayed catalysts favor patience.
BSXPositive Net Change JNJPositive Net Change MDTPositive Net Change
earnings-outlook earnings-performance earnings-report earnings-surprise medical medical-devices
Can MEDP's Record Q2 Bookings Build a Stronger Growth Path for 2027?
by Moumi Mondal
Medpace posted record Q2 awards and a stronger book-to-bill ratio, but can backlog conversion and study timing turn renewed demand into stronger 2027 growth?
MEDPPositive Net Change ICLRPositive Net Change IQVPositive Net Change
earnings-performance medical medical-devices
Thermo Fisher Raises 2026 Outlook After Strong Second-Quarter Results
by Moumi Mondal
TMO lifted its 2026 outlook after Q2 topped estimates, driven by stronger demand, acquisitions and margin gains. Can the momentum continue?
TMOPositive Net Change DHRPositive Net Change APositive Net Change
earnings-performance medical medical-devices
Why Is FactSet (FDS) Up 5.2% Since Last Earnings Report?
by Zacks Equity Research
FactSet (FDS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
FDSPositive Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
General Mills (GIS) Down 3.1% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
General Mills (GIS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
GISPositive Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Constellation Brands (STZ) Down 3.8% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Constellation Brands (STZ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
STZPositive Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate